Rich LegacyGlorious Future

The JB Pharma story is one of passion and performance. Our humble beginnings more than 4 decades ago, set a strong foundation of principles before performance, and a focus on building quality relationships.

This foundation has seen us achieve a lot of significant milestones: from our first international operations, first accreditations, first products to today being India’s fastest growing pharmaceutical company (IQVIA, FY 2020). Our journey is one of consistent growth and delivering value: to patients, healthcare providers, partners, distributors and all stakeholders.

45 years

 
 
1976
 
 
1st brick in the foundation laid by late Mr. J.B. Mody by incorporating J.B. Chemicals & Pharmaceuticals Laboratories (JBCPL).
1977
 
 
Introduced the product Metrogyl, that went on to become the “Gold-Standard” brand of anaerobicidal, anti-protozoal. It remains unbeaten even today.
1985
 
 
Forayed into the cardiac segment with the revolutionary product Nicardia.
1985
 
 
Got publicly listed and expanded from API to Formulations.
1986
 
 
Rantac was introduced which soon became choice of healthcare professionals in turn making it an iconic brand. Not only its the highest prescribed brand of ranitidine, it is also one of the largest selling pharmaceutical brand in India even today.
2000
 
Capitalised on the vast Russia & CIS OT market with 2 Brands: Doctor Mom & Rinza.
2003
 
 
Received first FDA approval for our Panoli Plant:T10.
2007
 
 
Launched the product Cilacar that went on to become a leading brand in cardiology and nephrology. The brand today is one of the highest selling brand in anti hypertensive category.
2008
 
 
Made a strategic investment in a company in South Africa called Biotech Laboratories.
2016
 
 
Received a silver award from the United States Pharmacopeia (USP) for participation in the Monograph Development & Upgradation Program and preparation and distribution of USP reference substance.
2020
 
 
Leading private equity firm Kohlberg Kravis Roberts & Co. Inc. (KKR), acquired a controlling stake of JBCPL.
2021
 
 
Ranked 28th in the industry (ORG- IMS) with 5 brands: Rantac (Anti-Peptic Ulcerant), Metrogyl (Amebicides), Nicardia (Calcium Channel Blocker)  and Cilacar-T featuring in top 300 brands of the Indian pharmaceutical market.